PHARM Connect Congress to be held in Budapest, Hungary on February 25-26, 2015

400 senior decision makers together from over 23 countries with more than 35 solution provider companies

The fifth annual PHARM Connect Congress to be held in Budapest, Hungary on February 25-26, 2015 will bring more than 400 senior decision makers together from over 23 countries with more than 35 solution provider companies. Express Pharma is the media partner for the event.

Leading service providers of the pharmaceutical and biotechnology sector, covering a wide range of profiles from API’s and contract manufacturing to processing, biopharma solutions, biopharmaceuticals and biologicals, drug delivery systems, clean rooms, laboratory equipment, monitoring systems, inspection systems, quality control, measurement systems, data loggers, packaging and labelling, automation, plant engineering and maintenance, logistics, cold chain storage and distribution, warehousing and many others will have the opportunity to meet the key decision makers of their targeted companies. This event presents a unique opportunity to develop fruitful, long-term and valuable business relations.

Service providers will meet and interact with leading practitioners and industry experts during numerous pre-scheduled one-to-one business meetings and additional informal networking activities.

Discussions will be held on the following topics: Industrial Internet drives productivity and efficiency in the life sciences industry by Terry Siggins, GE Intelligent Platforms; SmartFactories: Time and Cost Efficient Bio-Pharma from R&D to GMP by Dr Barbara Paldus, Finesse Solutions; Continued Process Verification by Dr Joerg Gampfer, Baxter; Supergeneric Drug Development by Prof Dr Vladimir Kral, Global Director Development Science & Innovation, Zentiva; Trends and growth potentials of biosimilars – Advantage or Threat?- Dr Erik Bogsch, Gedeon Richter; Expectations, benefits, difficulties and facing reality during the implementation of continued process verification by Dr Zsolt Németh, GSK Vaccines; Injectables-elastomers stoppers for injectables by Arnaud Fournier,Aptar Stelmi & Olivier De Gall, Aptar Stelmi; ‘SupraMotion – Future Concept for Pharmaceutical Production?’ by Thomas Schulz, FESTO and Strategies in the development of generic APIs, Prof Dr Josef Hajicek, Zentiva.

The panel discussions will give a platform to discuss: Continued process verification- Dr Zsolt Németh, GSK Vaccines & Miroslava Čikošová, Lonza Biotec and Dr Joerg Gampfer, Baxter & Lenka Franciskovic, Belupo; How to fight against counterfeiting – Who & how?- Prof Dr Tamás Paál,National Institute of Pharmacy Directorate (GYEMSZI) and Erzsébet Ódor, Sanofi and Dr Krisztina Székely, National Board against Counterfeiting and Dr Ibolya Csákó, Hungarian NationalPolice Headquarters Criminal Department.